Novavax | NVAX - Market Capitalization


Novavax reported $1.14B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 4.34B 845M Dec/2025
Agenus USD 107M 16M Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Cassava Sciences USD 96M 45M Dec/2025
Geron USD 843M 31M Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025